The Centers for Disease Control and Prevention yesterday issued a health advisory warning of an uptick over the last year in meningococcal disease in which isolates show the gene associated with penicillin resistance and mutations associated with ciprofloxacin resistance.

CDC said the majority of cases were in Hispanic individuals.

The agency recommends the following for providers and clinicians:

  • Health care providers should perform antimicrobial susceptibility testing to determine susceptibility of all meningococcal isolates to penicillin before changing from empirical treatment with cefotaxime or ceftriaxone to penicillin or ampicillin.
  • In states that have experienced meningococcal disease cases caused by ciprofloxacin-resistant strains within the past 1–2 years, clinicians and public health staff should consider AST on meningococcal isolates to inform prophylaxis decisions. AST should not delay the initiation of prophylaxis with ciprofloxacin, rifampin or ceftriaxone.

Related News Articles

Headline
Health care providers should know the symptoms of acute flaccid myelitis and immediately hospitalize those who exhibit them, the Centers for Disease Control…
Headline
The AHA, the American Medical Association and American Nurses Association today partnered to release a public service announcement urging the American public…
Headline
A new AHA issue brief outlines five actions that hospitals and health systems can take to address housing instability and improve health in their communities…
Headline
The AHA today announced it is honoring five hospital-led partnerships with the AHA Dick Davidson NOVA Award for each program’s efforts to improve community…
Headline
The Centers for Disease Control and Prevention yesterday said it is investigating a multistate outbreak of Salmonella Newport infections. CDC said 125 people…
Headline
As urged by the AHA, the IRS late yesterday announced that it is expanding the July 15 extension of time for tax-exempt hospitals to meet their community…